Insights

Strategic Acquisition PathoQuest has become part of Charles River Laboratories, signaling potential enterprise-level collaborations and cross-sell opportunities within a larger biosafety and biopharma testing portfolio across GMP-compliant NGS services.

NGS Leadership As a global CRO specializing in Next-Generation Sequencing based biosafety and genetic characterization, PathoQuest offers high-value, animal-free testing that can be positioned to biotechs and CMOs seeking faster release with regulatory-compliant NGS assays.

Facility Footprint With testing capabilities in Paris and Wayne, PA, there are co-location and regional access angles for sales outreach to European and North American biopharma, as well as potential partner referrals through Charles River’s existing network.

Leadership & Growth Recent executive appointments and a history of commercial leadership changes indicate ongoing investments in market expansion, enabling proposals for expanded service scopes, territories, and integrated biosafety offerings.

Expansion Signals Upcoming events such as the Next-Gen Biosafety Masterclass present opportunities to engage industry regulators and potential clients, creating pathways for partnerships, pilot studies, and thought-leadership-driven outreach.

Similar companies to PathoQuest

PathoQuest Tech Stack

PathoQuest uses 8 technology products and services including iCIMS, Amazon Web Services, HashiCorp Terraform, and more. Explore PathoQuest's tech stack below.

Media & News

PathoQuest's Email Address Formats

PathoQuest uses at least 4 email formats:
PathoQuest Email FormatsExamplePercentage
First.Last@pathoquest.comJohn.Doe@pathoquest.com
83%
FLast@pathoquest.comJDoe@pathoquest.com
14%
First.Middle@pathoquest.comJohn.Michael@pathoquest.com
2%
FirstLast@pathoquest.comJohnDoe@pathoquest.com
1%

Frequently Asked Questions

What is PathoQuest's phone number?

Minus sign iconPlus sign icon
You can contact PathoQuest's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PathoQuest's official website and social media links?

Minus sign iconPlus sign icon
PathoQuest's official website is pathoquest.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does PathoQuest generate?

Minus sign iconPlus sign icon
As of October 2026, PathoQuest's annual revenue is estimated to be $1M - $10M.

What is PathoQuest's SIC code and NAICS code?

Minus sign iconPlus sign icon
PathoQuest's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PathoQuest have currently?

Minus sign iconPlus sign icon
As of October 2026, PathoQuest has approximately 59 employees across 2 continents, including Europe and North America. Key team members include Coo: G. D., Chief Commercial Officer (cco): M. D. and Chief People And Financial Officer: E. C. Explore PathoQuest's employee directory with LeadIQ.

What industry does PathoQuest belong to?

Minus sign iconPlus sign icon
PathoQuest operates in the Biotechnology Research industry.

What technology does PathoQuest use?

Minus sign iconPlus sign icon
PathoQuest's tech stack includes iCIMS, Amazon Web Services, HashiCorp Terraform, WordPress, Salesforce, Salesforce Marketing Cloud Account Engagement, WP Engine and Piwik PRO Core.

What is PathoQuest's email format?

Minus sign iconPlus sign icon
PathoQuest's email format typically follows the pattern of First.Last@pathoquest.com. Find more PathoQuest email formats with LeadIQ.

How much funding has PathoQuest raised to date?

Minus sign iconPlus sign icon
As of October 2026, PathoQuest has raised $41M in funding. The last funding round occurred on Nov 09, 2021 for $17M.

When was PathoQuest founded?

Minus sign iconPlus sign icon
PathoQuest was founded in 2010.
PathoQuest logo

PathoQuest

Biotechnology ResearchÎle-de-France, France51-200 Employees

PathoQuest is a global contract research organization specializing in biosafety testing for biologics, employing next-generation sequencing to support the rapid and safe release of therapies to patients. Its iDTECT suite provides GMP-validated assays for assessing viral safety and for genetically characterizing raw materials as well as cell and gene therapies, monoclonal antibodies, and vaccines. The company is based in Paris, Île-de-France, with testing capabilities in Paris and Wayne, Pennsylvania.

Its customers are biopharma and biotech manufacturers seeking biosafety testing and genetic characterization to meet regulatory requirements. Operating across Europe and North America, PathoQuest positions itself as a specialized CRO at the intersection of biosafety and sequencing-based analytics. In February 2026 the company announced the launch of a Next-Gen Biosafety Masterclass addressing the use of sequencing in biosafety testing from regulation to routine practice.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
51-200

Section iconFunding & Financials

  • $41M

    PathoQuest has raised a total of $41M of funding over 6 rounds. Their latest funding round was raised on Nov 09, 2021 in the amount of $17M as a Series B.

  • $1M - $10M

    PathoQuest's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.